Header Ads Widget

Prospectus – Fully Underwritten Pro- rata Non-renounceable Rights Issue and Shortfall Offer

EMU NL presents this Prospectus dated 4 June 2024 and was lodged with ASIC on that date with the consent of all Directors. None of ASIC, ASX or their respective officers or employees takes any responsibility for the contents of this Prospectus.

Prospectus for the: (i) offer (Offer) of a fully underwritten pro rata non-renounceable entitlement issue of approximately 48,005,533 fully paid, ordinary shares in the capital of the Company (FPO Shares) at an issue price of $0.025 per FPO Share to Eligible Shareholders on the basis of three (3) new FPO Shares for every five (5) Shares held as at 5.00pm (WST) on Friday 7 June 2024 (the Record Date) to raise approximately $1,200,138 (before costs and assuming no other Shares are issued before the Record Date); and (ii) offer (Shortfall Offer) to Eligible Shareholders and other investors to apply for additional Shares comprising Shortfall Shares arising as a consequence of any FPO Shares not being applied for and issued as of Entitlement.

Shortfall Shares will be allocated by the Directors in priority to Eligible Shareholders, subject to the overriding discretion of the Board (including as to scale backs), with any residual Shortfall Shares not allocated to Eligible Shareholders to be allocated by the Company in consultation with the Underwriter subject to the terms of the Underwriter Agreement as disclosed herein.

The Offer is fully underwritten by Martin Place Securities Pty Limited (Underwriter).

The Offer opens on 13 June 2024 and closes at 5.00pm (WST) on 26 June 2024 (unless it is lawfully extended or withdrawn).

Only payments by BPAY® or EFT will be accepted by the Company.

Click here for the full ASX Release

This article includes content from EMU NL, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.


댓글 쓰기

0 댓글